Document is current
Any future updates will be listed below
-
Authors
Hacker, Stephan M. https://orcid.org/0000-0001-5420-4824
Backus, Keriann M. https://orcid.org/0000-0001-8541-1404
Lazear, Michael R.
Forli, Stefano https://orcid.org/0000-0002-5964-7111
Correia, Bruno E.
Cravatt, Benjamin F. https://orcid.org/0000-0001-5330-3492
- License Information
-
More Information
Article History
Received: 26 February 2017
Accepted: 7 June 2017
First Online: 31 July 2017
Competing interests
: The authors declare competing financial interests. B.F.C. is a founder and advisor to Vividion Therapeutics, a biotechnology company interested in using chemical proteomic methods to develop small-molecule drugs to treat human disease.
